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CLINICAL STUDY 
Abstract   
Objective  
To examine the prevalence of cryoglobulinaemia in patients with chronic hepatitis C 
infection and its relation to extrahepatic neuro-cutaneous manifestations.  
 Methods 
 Forty patients (26 males & 14 females), with clinical, laboratory and histologically 
established chronic hepatitis C infection, with a mean age of 37.5 years,  were submitted to 
clinical examination, dermatological and neurological evaluation. Neuroimaging as well 
as neurophysiological evaluation, laboratory assessment including liver function tests, 
serum cryoprecipitate immunoelectrophoresis, and revision of histopathlogical findings 
were performed. 
Results 
A high prevalence of cryglobulenemia: 62.5% in patients with chronic hepatitis C 
infection, the presenting symptoms were fatigue (67.5%), arthralgia (32.5%), paresthesia 
(30%) and pruritus (25%); however, there were no statistically significant difference 
between cryo +ve versus cryo –ve patients except for pruritis, and face pigmentation. Skin 
manifestations including face pigmentation (42.5%), leukocytoclastic vasculitis (22.5%), 
porphyria cutanea tarda (20%), lichen planus (17.5%), acral necrolytic erythema (15%) and 
vitiligo (15%). Neurological manifestations ; symptomatic neuropathy in 10%, neuropathic 
changes in 30% and electroencephalographic changes in 22.5%. These cutaneous and 
neurological manifestations were significantly associated with the presence of 
cryoglobulinaemia.  
Conclusion  
Our findings support an association between cryoglobuliaemia and extrahepatic 
neurocutaneous manifestations of hepatitis C infection. The presence of all these 
manifestations in the appropriate clinical setting should suggest the presence of hepatitis 
C  infection.   
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Introduction 
  
owadays, there is an increasing 
awareness of a variety of extrahepatic 
syndromes that seem to be associated with 
HCV infection1 .  
Pascual et al2 reported two patients with 
chronic HCV infection and essential mixed 
cryoglobulinaemia (EMC). Since then, a 
considerable number of extrahepatic 
syndromes has been reported as described 
by Nocente et al3. 
Cryoglobulinaemia (Cg) is a condition 
characterized by the presence of serum 
proteins that reversibly precipitate in cold4 
and are classified on the basis of their 
immunoglobulin composition according to 
Brouet et al5.  The clinical manifestations of 
mixed cryoglobulinaemia (MC) range from 
asymptomatic, mild vasculitis with palpable 
purpura, arthralgia and fatigue, to severe 
vasculitis with skin necrosis6, involvement 
of the kidneys7, peripheral nerves8, and  
centeral nervous system9. Fifty percent of 
patients with chronic HCV, show detectable 
cryoglobulinaemia, even though most of 
them do not show cryoglobulinaemia 
related symptom10. Factors involved in the 
production of Cg in HCV infected patients 
are unknown; most likely the presence of 
HCV in the cells of the immune system and 
/or chronic stimulation of the immune 
response by HCV. Also, genetic factors may 
be involved in the pathogenesis of Cg. Little 
is known about the clinical significance of 
Cg in the course of chronic HCV11.  
Neurological manifestations of HCV have 
been less well characterized and reported, 
including peripheral nerve vasculitic 
neuropathy, and also intracranial 
vasculopathy12,13. Peripheral neuropathy is 
present in most of the patients with 
symptomatic cryoglobulinaemia where it 
may be the first clinical manifestations10. In 
1998, Origgi and Colleagues14, described 3 
patients who complained of mild CNS 
problems, including confusion and 
disequilibrium and magnatic resonance 
imaging (MRI) of these patients showed 
small hyperintensities consistant with 
ischaemic lesions. In Heckmann et al9. 
review of a small series of HCV-infected 
patients showing neurological 
manifestations, a patient with systemic 
vasculitis associated with systemic 
cryoglobulinaemia is described who 
progressed from apathy to severe 
drowsiness with myoclonic jerks and 
multiple pyramidal tract signs and MRI 
showed increased prolonged Spin echo 
signal diffusely throughout the deep white 
matter that resemble HIV-associated 
leukoencephalopathy.  
Chronic HCV is associated with and may 
trigger or exacerbate an extraordinary 
variety of extrahepatic skin  manifestations, 
the most frequent and important of which 
are the leukocytoclastic vasculitis (LCV) of 
mixed cryoglobulinaemia type 2 and 
porphyria cutinea tarda (PCT)15. Cutaneous 
symptoms relevant to HCV infection 
manifest in 20 – 40 % of patients presenting 
to dermatologists and in a significant 
percentage (15 – 20 %) of general patients 
and HCV are suggested and must appear in 
the differential diagnosis of these patients to 
avoid missing this important but occult 
factor in clinical disease in the appropriate 
setting16. Leukocytoclastic vasculitis (LCV) 
due to cryoglobulinaemia is a good example 
of a specific skin manifestation resulting 
from the production of immunoglobulins 
with rheumatoid factor characteristics 
causing an immune complex- mediated 
vasculitis while Porpheria cutanea tarda 
(PCT) is a good example of HCV-related 
disease in which causation is undeniable 
where 70 % of patients with PCT have 
HCV16. The objective of this work was to 
determine the prevalence of Cg in our 
patients with chronic HCV infection and its 
relation to the neuro-cutaneous extrahepatic 
manifestations. 
Materials and Methods 
 
Forty patients (26 males and 14 females), 
with established diagnosis of chronic HCV 
(clinical, laboratory and histopathological), 
with a mean age of 37.5 years were studied. 
Exclusion criteria were the following:  
1. Chronic hepatitis C patients with Fibrosis 
score ( F ) beyond F1  
2. Other    liver   diseases    including the
N
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schistosomiasis, hepatitis B, autoimmune or 
drug-induced hepatitis.  
3.The presence of other causes of 
cryoglobulinaemia including HIV, 
malignancy, or other chronic diseases .  
4. Previous antiviral therapy in the patient 
population before their assessment.                          
Patients were selected from patients who 
were evaluated for antiviral therapy at the 
Clinic of Gastroenterology and Hepatology 
of Specialized Medical Hospital Mansoura 
University during January 2004 to January 
2006. Patients were submitted to clinical 
examination, dermatological and 
neurological evaluation, neuroimaging 
study (CT and MRI brain) as well as 
neurophysiological evaluation, laboratory 
assessment including liver function tests, 
serum cryoprecipitate immune-
electrophoresis, antinuclear antibody, 
rheumatoid factor as well as abdominal 
ultrasound and revision of histopathlogical 
findings.    
Detection of Cryoglobulins 
The thermolability of cryoglobulins 
necessitated that the blood samples be 
collected at 37°C. Syringes and collection 
tubes were at 37°C at the time of blood 
collection and maintained at 37°C until 
clotting is completed. Tubes for collection 
were not anticoagulated, since the use of 
plasma may result in the development of 
cold-precipitable fibrinogen (cryofibrinogen) 
or heparin-precipitable protein. Blood 
Sampling10mL of blood in a warm syringe 
(37°C) were collected.  
Analysis Process: 
 A white precipitate (cryoglobulin) appeared 
in the serum after 24-72 hours of storage at 
4°C.  The serum was tested for the 
reversibility of the cryoprecipitate by re- 
warming an aliquot at 37°C for 24 hours.  
 
 
The cryocrit was estimated by measuring 
the height of the column of precipitated 
protein relative to the height of the serum 
column17.   
Liver histology was evaluated according to 
the standard international criteria using 
Metavir Score (Table 1). 
Statistical Methods  
Frequency, mean, standard deviation and 
standard error of mean were used to 
describe data. 
Mann-Whitney P test was used to test for 
significance of difference in quantitative 
variables between each two groups.   
Chi-square test was used to test for 
association between groups and clinical 
categorical data. P value was considered 
significant if < 0.05.     
These tests were run on an IBM compatible 
personal computer using the Statistical 
Package for Social scientists (SPSS) for 
windows 7.5 (SPSS Inc, Chicago, IL, USA).   
The study protocol was approved by human 
ethics committee of Specialized Medical 
Hospital Mansoura University.
As regard to laboratory findings including 
liver function tests (SGPT, serum bilirubin 
and prothrombin time), urine analysis (for 
proteinuria), serum creatinine, ANA, RF and 
quantitative PCR for HCV-RNA, there were 
no statistically significant difference 
between cryo +ve and cryo –ve patients 
except for proteinuria. 
Concerning the liver histopathological 
findings (evaluated according to Metavir 
score) there were no statistically significant 
difference in activity score between cryo +ve 
versus cryo –ve patients. 
 
Results  
 
The results are shown in Tables 2-5. 
Table 1: Metavir Score A0-3 (Activity)  F0-4 (Fibrosis) 18 
Activity A0 (None) A1 (Mild) A2 
(Moderate) 
A3 (Severe)  
Fibrosis F0 F1 F2 F3 F4 
Activity (A): An algorithm of both piecemeal and parenchymal necrosis 
Fibrosis (F): Non, F1: Portal tract expansion by fibrosis, F2: <50% bridging fibrosis, F3: >50% bridging 
fibrosis including incomplete cirrhosis, F4: Established cirrhosis 
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 Table 2: Demographic data, clinical characteristics, skin & neurological manifestations 
Features Frequency Descriptive (n=40) 
n % Mean SD 
Sex:    female 
            male 
14 
26 
35 
65 
 
 
 
 
 
 
 
 
 
 
37.53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9.16 
Fatigue 27 67.5 
Parasthesia 12 30 
Arthralgia 13 32.5 
Pruritis 10 25 
Edema 2 5 
Face Pigmentation 17 42.5 
Jaundice 12 30 
BMI:      low 
                average 
                over 
7 
22 
11 
17.5 
55 
27.5 
Leucocytoclastic vasculitis 9 22.5 
PCT 8 20 
Lichen Planus 7 17.5 
Acral NE 6 15 
Vetiligo 6 15 
Symptomatic Neuropathy 4 10 
Myopathic 0 0 
Fits 0 0 
EMG: neuropathic 12 30 
NCV: delayed 12 30 
EEG: abnormalities 9 22.5 
 
Table  2 shows the demographic details, patient clinical characteristics, skin and the neurological 
manifestations of the studied patients. Among 40 patients with chronic hepatitis C, there were 26 male 
(65%) and 14 female (35%). The main age of the patients was 37.5 years. The most common symptom was 
fatigue 27 cases (67.5%). Leukocytoclastic vasculitis was the main skin lesion  9 cases(22.5%) followed by 
porphyria cutenia tarda 8 cases (20%) and Lichen planus 7 cases (17.5%). Symptomatic neuropathy was 
only found in 4 cases (10%) while in 12 cases (30%) neuropathy was detected by nerve conduction velocity 
and EMG. EEG changes were detected in 9 cases (22.5%). 
 
Discussion  
 
The present study demonstrated a high 
prevalence of Cg: 62.5% in patients with 
chronic HCV infection. Different studies 
showed wide variation from 19% - 57%19-21. 
These discrepancies may be caused by 
different Cg detection methods and a strong 
regional differences.  
Many skin lesions were detected in the 
studied patients; including face 
pigmentation (42.5%), leukocytoclastic 
vasculitis (LCV) (22.5%), porphyria cutanea 
tarda (PCT)(20%), lichen planus (17.5%), 
acral necrolytic erythema (15%) and vitiligo 
(15%). Arthur et al16 found that cutaneous 
symptoms or findings relevant to HCV 
infection manifest in 20 – 40 % of patients 
presenting to dermatologists and in a 
significant percentage (15 – 20 %) of general 
patients. 
Neurological manifestations, including 
symptomatic neuropathy in 10%, 
neuropathic changes (demyelinating 
neuropathy) detected by nerve conduction 
velocity (NCV) and electromyography 
(EMG) in 30%, also electroencephalographic 
changes in 22.5%. Our results are in 
accordance with that of Zaltron et al10, 
Ripault et al13, Bonetti et al22, and Arthur et  
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al16. These cutaneous and neurological 
manifestations detected in the studied 
patients were significantly associated with 
the presence of cryoglobulinaemia.
 
  Table 3: Comparison of clinical characteristics in cryo +ve versus cryo –ve patients
Features Cryoglobulinemia Chi square 
-ve +ve X2 P 
Fatigue 9 18 0.615 0.433 
Parasthesia 3 9 1.143 0.285 
Arthralgia 4 9 0.372 0.542 
Pruritis 0 10 8.000 0.005 
Edema 0 2 1.263 0.261 
Face Pigmentation 1 16 12.610 0.000 
Jaundice 5 7 0.127 0.722 
BMI:            low 
                     average 
                     over 
6 
8 
1 
1 
14 
10 
10.743 0.005 
 
Table 3 shows comparison of clinical characteristics in cryo+ve { 25/40 (62.5%) }versus Cryo –ve patients 
{ 15/40 (32.5%) }. Cryoglobulinaemia was detected in 25 cases (62.5%). There were no statistically 
significant difference in clinical characteristics between Cryo –ve and Cryo +ve cases apart from pruritis, 
face pigmentation and BMI. 
 
Table 4: Relation of skin manifestations in patients with and without cryoglobulinemia
Features Cryoglobulinemia Chi square 
-ve +ve X2 P 
Leucocytoclastic vasculitis  0 9 6.968 0.008 
Spider nevai 1 9 4.302 0.038 
Palmar Erythema 0 9 6.968 0.008 
PCT 0 8 6 0.014 
Lichen Planus 0 7 5.091 0.024 
Acral NE 0 6 4.235 0.04 
Vitiligo 0 6 4.235 0.04 
 
Table 4 shows the relation of skin manifestations in cryoglobulinemia +ve versus Cryoglobulinamia –ve 
patients. Skin lesions including leucocytoclastic vasculitis, spider nevai, palmer erythema, PCT, Lichen 
Planus, Acral NE & Vetiligo showed statistically significant difference between cryo +ve and cryo -ve 
cases. 
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Table 5 : Comparison of neurologic findings ( clinical and neurophysiological) in Cryo+ve 
versus Cryo–ve patients
Features Cryoglobulinemia Chi aquare 
-ve +ve X2 P 
Symptomatic 
neuropathy  
 
0 
21 
4 
 
2.667 
 
0.102 
Myopathy  
0 
25 
 
- - 
Fits  
0 
25 
 
- - 
 
EMG: Neuopathic 
 
0 
 
12 
 
10.286 
 
0.001 
 
NCV: Delayed 
 
0 
 
12 
 
10.286 
 
0.001 
 
EEG: Abnormal 
 
0 
 
9 
 
6.968 
 
0.008 
 
Table 5  showed comparison of neurologic fidings ( clinical and neurophysiological) in Cryo+ve versus 
Cryo–ve patients.There were no statistically significant difference between Cryo+ve and Cryo–ve patients 
for symptomatic neuropathy while there were statistically significant difference for abnormalities detected 
by electrophysiological studies( EMG, NCV & EEG ). 
 
 Origgi et al14 stated that cryoglobulinaemia 
may be one of the mechanisms ( vasculitis 
associated with cryoglobulinaemia and or 
multiple ischaemic changes ) underlying 
cutaneous and neurological manifestations 
associating HCV infection. 
Chronic sensory polyneuropathy was the 
most frequent neurological manifestation,  
and this was the same as findings by Nemni 
et al23 who found that the prevalence of 
polyneuropathy was significantly higher in 
cg +ve versus cg –ve patients, however, 
Paoletti et al24 and Lidove et al25 reported 
some HCV+ve patients with 
polyneuropathy and persistent negativity 
for cryoglobulins.  
Proteinuria was present in 22.5% of cryo 
positive patients in the current study. 
Valentina et al26 found that the presence of 
proteinuria correlated with very high 
cryocrit level. Other biochemical parameters 
and Quantitative PCR in the studied 
patients, showed no statistically significant 
difference between cryo positive and cryo 
negative patients. These were in accordance 
with Horcajada et al 11 and valentina et al26. 
Liver histopathology of the studied patients 
according to METAVIR score (Activity)A0-3 
(Fibrosis)  F0-4    showed     no     statistically 
 
significant difference between cryo positive 
versus cryo negative patients. These 
observations are in accordance with the data 
reported by Valentina et al26 and Schmidt et 
al21 who also found no correlation between 
the amount of Cg and histological activity.  
Sansonno and Dammacco27 reported that 
HCV-infected people with cryoglobulinemic 
vasculitis frequently show minimal liver 
damage and normal or slightly increased 
levels of serum aminotransferases.  
Several authors have reported a higher 
prevalance of Cg in patients with HCV-
induced liver cirrhosis than in chronic 
hepatitis C without cirrhosis; however, this 
observation has not been confirmed by 
others Lunel et al28. Also, Wong et al19  
reported no differences in the stage of 
fibrosis between patients with and without 
cryoglobulinaemia.  
Conclusion 
Our findings confirmed a clear association 
between cryoglobuliaemia and extrahepatic 
neurocutaneous manifestations of HCV 
infection. The presence of these 
manifestations in the appropriate clinical 
setting should suggest the presence of HCV 
infection and HCV antibodies should be 
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tested and, if positive, HCV-RNA is 
indicated and if there is any evidence of an 
etiological association of replicative HCV 
infection and these extrahepatic 
manifestations, antiviral treatment should 
be considered.  
We are in need to extend this work to study 
Hepatitis C virus induced cryo 
globulinaemia  quantitatively ; essential 
mixed cryoglobulinaemia (EMC), and  to 
assess if it has any role in HCV-liver disease 
progression.         
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